Urelle

Urelle

Urelle Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

If rapid pulse, dizziness, or blurring of vision occurs, discontinue use immediately.

Patients should be advised that urine will be colored blue when taking this medication. Do not exceed recommended dosage.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Urelle® is indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.

History

There is currently no drug history available for this drug.

Other Information

Urelle® tablets for oral administration are supplied as navy blue round tablets with “A-002” debossed on one side.

Each Tablet Contains:

Hyoscyamine Sulfate 0.12 mg

Methenamine 81.0 mg

Methylene Blue 10.8 mg

Phenyl Salicylate 32.4 mg

Sodium Phosphate Monobasic 40.8 mg

INACTIVE INGREDIENTS:

Corn Starch, Dicalcium Phosphate, FD&C Blue #2/Indigo Carmine Aluminum Lake, Magnesium Stearate, Microcrystalline Cellulose, Polyethylene Glycol, Polyvinyl Alcohol, Talc, Titanium Dioxide.

Urelle Manufacturers


  • Meda Pharmaceuticals Inc.
    Urelle (Hyoscyamine Sulfate, Methenamine, Methylene Blue, Phenyl Salicylate, And Sodium Phosphate, Monobasic, Monohydrate) Tablet [Meda Pharmaceuticals Inc.]
  • Jazz Pharmaceuticals Commercial Corp.
    Urelle (Hyoscyamine Sulfate, Methenamine, Methylene Blue, Phenyl Salicylate, And Sodium Phosphate, Monobasic, Monohydrate) Tablet [Jazz Pharmaceuticals Commercial Corp.]

Login To Your Free Account